Kerendia

Finerenone, sold under the brand name Kerendia, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type2 diabetes.[2] Finerenone is a non-steroidal mineralocorticoid receptor antagonist (MRA).[1] Common side effects include hyperkalemia (high levels of potassium), hypotension (low blood press... [wikipedia]